4
Sistemas Genómicos is a pioneering company in the application of Next Generation Sequencing technology for genetic diagnosis. Accredited and certified by the major entities in quality assurance (ENAC, AENOR and CLIA), we offer solutions to accelerate and standardize clinical genetic testing, enabling clinicians to provide accurate diagnostics to their patients. We strive to provide the best diagnostic solutions with the best technology and knowledge available to maximise patient benefit. Our integrated systems have helped labo- ratories for the last two decades to improve their diagnos- tics and research work, by developing a unique range of CE-IVD solutions. ABOUT US HIGHLIGHTS Onco-GeneSGKit ® OUR MISSION Sistemas Genómicos has designed the Onco-GeneSGKit ® series for the study of up to 111 genes related with hereditary cancer of heterogeneous origin. Thanks to the Onco-GeneSGKit ® , a range of pathologies can be studied, such as Breast and Ovarian Cancer, Bowel cancer, Familial Adenomatous Polyposis, Hamartomatous Polyposis, Juvenile Polyposis, Peutz-Jeghers Syndrome, Cowden, Bannayan-Riley-Ruvalcaba, Fanconi Anemia, Endocrine Tumours, etc. 1 2 3 The most complete solution on the market The Onco-GeneSGKit ® is cleared for CE-IVD and contains reagents to process twelve samples with the corresponding bioinformatics analysis and visualization by the GeneSystems ® platform, which is CE-IVD marked. Fast workflow and low input requirements The libraries are ready within nine hours of work starting with 35 ng of DNA Complete bioinformatic analysis and data visualization The bioinformatics pipeline is executed in less than 48 hours, providing the user with a rich variant annotation including public, private and Sistemas Genómicos’ reference databases. This comprehensive annotation reports SNPs and indels, which are visualized and easily filtered on GeneSystems ® . CNVs detection Sensitive CNVs detection validated in prestigious public and private organisations. 1 *HiSeq and MiSeq. Other sequencing platforms in validation GeneSGKits ® library preparation Sample sequencing on Illumina* platforms Analysis and data interpretation on GeneSystems

Onco-GeneSGKit - tataa · The Onco-GeneSGKits® are cleared for CE IVD and contain reagents for processing twelve samples with the corresponding bioinformatic analysis on the GeneSystems

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Onco-GeneSGKit - tataa · The Onco-GeneSGKits® are cleared for CE IVD and contain reagents for processing twelve samples with the corresponding bioinformatic analysis on the GeneSystems

Sistemas Genómicos is a pioneering company in the application of Next Generation Sequencing technology for genetic diagnosis. Accredited and certified by the major entities in quality assurance (ENAC, AENOR and CLIA), we offer solutions to accelerate and standardize clinical genetic testing, enabling clinicians to provide accurate diagnostics to their patients.

We strive to provide the best diagnostic solutions with the best technology and knowledge available to maximise patient benefit. Our integrated systems have helped labo-ratories for the last two decades to improve their diagnos-tics and research work, by developing a unique range of CE-IVD solutions.GRAFICO WORKFLOW

ABOUT US

HIGHLIGHTS

Onco-GeneSGKit®

OUR MISSION

Sistemas Genómicos has designed the Onco-GeneSGKit® series for the study of up to 111 genes related with hereditary cancer of heterogeneous origin. Thanks to the Onco-GeneSGKit®, a range of pathologies can be studied, such as Breast and Ovarian Cancer, Bowel cancer, Familial Adenomatous Polyposis, Hamartomatous Polyposis, Juvenile Polyposis, Peutz-Jeghers Syndrome, Cowden, Bannayan-Riley-Ruvalcaba, Fanconi Anemia, Endocrine Tumours, etc.

1 2 3

The most complete solution on the market

The Onco-GeneSGKit® is cleared for CE-IVD and contains reagents to process twelve samples with the corresponding bioinformatics analysis and visualization by the GeneSystems® platform, which is CE-IVD marked.

Fast workflow and low input requirements

The libraries are ready within nine hours of work starting with 35 ng of DNA

Complete bioinformatic analysis and data visualization

The bioinformatics pipeline is executed in less than 48 hours, providing the user with a rich variant annotation including public, private and Sistemas Genómicos’ reference databases. This comprehensive annotation reports SNPs and indels, which are visualized and easily filtered on GeneSystems®.

CNVs detection

Sensitive CNVs detection validated in prestigious public and private organisations.

1

*HiSeq and MiSeq. Other sequencing platforms in validation

GeneSGKits® librarypreparation

Sample sequencing on Illumina* platforms

Analysis and data interpretation on GeneSystems

Page 2: Onco-GeneSGKit - tataa · The Onco-GeneSGKits® are cleared for CE IVD and contain reagents for processing twelve samples with the corresponding bioinformatic analysis on the GeneSystems

The Onco-GeneSGKits® are cleared for CE IVD and contain reagents for processing twelve samples with the corresponding bioinformatic analysis on the GeneSystems platform. Developed in collaboration with experts in hereditary cancer, the Onco-GeneSGKit® series is designed for the study of up to 111 genes associated with predisposition to hereditary cancers. The workflow is optimised for library preparation in nine hours and the tech-nology used allows the combination of multiple samples prepared with different GeneSGKits® in a single run on Illumina sequencing platforms.

Onco-GeneSGKit®

DNA librarygDNA

GeneSGKit® Probes

Capture beads Unbound library

Captured library Indexing

Fast Hybridization

Captured and dual-indexed library

Sequencing

The GeneSGKits® offer excellent performance from only 35 ng of DNA. The capture probes are based on ultra-long RNA baits (120 nucleotides) with high sensitivity and spec-ificity for the detection of SNPs, indels and CNVs. Our probe design captures all the coding regions of each targeted gene, including splicing sequences.

DESIGN

With GeneSGKits® clinicians and researchers can be confident in the accuracy and reproducibility of the sequencing data. Each sample is sequenced with a mini-mum coverage of 20x in over 98% of the regions of inter-est for relevant pathologies, guaranteed by strict valida-tion protocols.

PERFORMANCE

A cutting-edge tool, GeneSystems makes it possible to access all your data on a 24/7 basis, thus allowing you to monitor the entire analysis process in real time. It includes advanced annotation tools to assist in diagnosis and research, including links to the latest public and private databases.

• User-friendly interface• All the diagnostic-relevant information in a single platform• Advanced filtering tools• 24/7 availability of results• Complete access to all the data, from raw data to annotated variants• Laboratory tools for optimally balanced sample pooling of libraries from different GeneSGKits® • Includes alignment, variant calling and data quality reports

GeneSystems

2

GeneSGKit® WORKFLOW

Page 3: Onco-GeneSGKit - tataa · The Onco-GeneSGKits® are cleared for CE IVD and contain reagents for processing twelve samples with the corresponding bioinformatic analysis on the GeneSystems

GeneSystems is designed to solve the different stages of the analytical data cycle of massive sequencing and provides solutions from the FASTQ files to the clinically-relevant data. GeneSystems captures annotations at gene, variant and transcript level and incorporates the most clinically relevant data-bases for the interpretation of variants, such as Ensemble, 1000Genomes, HGMDProfessional, dbSNP, RefSeq, Interpro, Prosite, Cosmic, HapMap, OMIM, ClinVar, ExAC, etc. Furthermore, GeneSystems users have access to the proprietary variant database of Sistemas Genómicos. Within the platform, there is also information on conservation scores, pathoge-nicity in silico predictors, flanking regions, among others. A one stop solution to find clinical meaning in your sequencing data.

GeneSystems provides a highly sensitive CNVs detection validated in prestigious public and private organisations, which optimizes the MLPA experiments thus reducing costs and diagnostic turnaround times.

DATA ANALYSIS

With the GeneSGKits® technology, clinicians and researchers will have the best tools for genetic diagnosis, thanks to the excellent quality of the sequencing data of the samples prepared with GeneSGKit. Each sample will be sequenced with low variance in the coverage values with 98% of the regions sequenced at a minimum depth of 20x.

HIGH DATA QUALITY

For Sistemas Genómicos, customer is at the center of our work. This includes a personalised service to enable a seamless implementation of diagnostic next generation sequencing. We offer personalised training programs to ensure a quick acquisition of the skill set required to successfully and reliably harness the latest advances in sequencing technology to maximize patient benefit.

SUPPORT

Onco-GeneSGKit® CATALOG

GeneSGKit® Size (MB) 12x 20x

% COVERAGE

Onco-GeneSGKit® 0,49 99,98 99,94

Onco-GeneSGKit® Mamma 0,21 100 100

Technical Data

Onco-GeneSGKit® Ref.: LV3658 (Kit IVD-CE) / LV3659 (Kit RUO)

Onco-GeneSGKit® Mamma Ref.: LV2537 (Kit IVD-CE) / LV3365 (Kit RUO)

References

3

Genes

111

2

Page 4: Onco-GeneSGKit - tataa · The Onco-GeneSGKits® are cleared for CE IVD and contain reagents for processing twelve samples with the corresponding bioinformatic analysis on the GeneSystems

Genes description

Onco-GeneSGKit®

[email protected]

+34 961 366 150

CDKN1B

CDKN2A

CHEK2

DDB2

DICER1

DIS3L2

DKC1

ELANE

EPAS1

EPCAM

ACD

AIP

APC

ATM

ATR

AXIN2

BAP1

BARD1

BLM

BMPR1A

FANCA

FANCB

FANCC

FANCD2

FANCE

FANCF

FANCG

FANCI

FANCL

FANCM

JAGN1

KIF1B

KIT

MAX

MDH2

MEN1

MET

MITF

MLH1

MNX1

NFIX

NHP2

NOP10

NSD1

NTHL1

PALB2

PARN

PDGFRA

PMS1

POLD1

RAD50

RAD51

RAD51C

RAD51D

RB1

RECQL

RECQL4

RET

RTEL1

SCG5

TERT

TINF2

TMEM127

TP53

TSC1

TSC2

UBE2T

VHL

VPS45

WASERCC1

ERCC2

ERCC3

ERCC4

ERCC5

ERCC6

BRCA1

BRCA2

BRIP1

BUB1

CDH1

CDK4

FH

FLCN

G6PC3

GFI1

GREM1

HOXB13

MSH2

MSH6

MSR1

MUTYH

NBN

NF2

POLE

POLH

POT1

PRKAR1A

PTCH1

PTEN

SLX4

SMAD4

SMARCA4

STK11

SUFU

TERC

WRN

WT1

XPA

XPC

XRCC2

Onco-GeneSGKit® Mamma

BRCA1

BRCA2